Serum lipids and stroke

Area of Science:

• Cardiovascular Science
• Neurology
• Metabolic Disorders

Background:

• Serum lipids and lipoproteins are established risk factors for coronary atherosclerosis.
• Their association with cerebrovascular atherosclerosis, including carotid artery disease, is less consistent but increasingly recognized.
• Specific lipid profiles, such as elevated low-density lipoprotein (LDL) and reduced high-density lipoprotein (HDL), correlate with atherosclerosis.

Purpose of the Study:

• To explore the relationship between serum lipids and lipoproteins and cerebrovascular atherosclerosis.
• To evaluate the utility of various lipid markers in assessing cranial atherosclerosis.
• To discuss the implications of cholesterol levels on stroke pathology and the challenges in post-stroke lipid assessment.

Main Methods:

• Review of existing studies correlating lipid levels with angiographic or ultrasonographic evidence of carotid artery atherosclerosis.
• Analysis of the role of conventional lipids, advanced lipoprotein markers (e.g., Lipoprotein (a), Apo B, Apo AI), and HDL subfractions.
• Discussion of the impact of total serum cholesterol levels on different stroke types (hemorrhage vs. atherothrombosis).

Main Results:

• Increased LDL and decreased HDL show a correlation with carotid artery atherosclerosis.
• Lipoprotein (a), apolipoproteins, and HDL subfractions may be superior indicators of cranial atherosclerosis compared to standard lipid panels.
• Cholesterol levels influence stroke type: low levels (<160 mg/dL) are linked to intracerebral hemorrhage, while high levels predispose to large vessel atherothrombosis.

Conclusions:

• While lipid profiles are linked to cerebrovascular disease, precise risk prediction and the impact of lipid-lowering interventions on stroke incidence require further investigation.
• The optimal timing for serum lipid and lipoprotein analysis following a stroke is not definitively established, with differing opinions on immediate versus delayed testing.
• Management of hyperlipidemia is crucial for reducing the risk of coronary heart disease and potentially subsequent strokes.